Carlson College of Veterinary Medicine

J. A. Hall, Yerramilli, M., Obare, E., Yerramilli, M., Melendez, L. D., and Jewell, D. E., “Letter to editor”, J Vet Intern Med, 2015.

J. A. Hall, Yerramilli, M., Obare, E., Yerramilli, M., Melendez, L. D., and Jewell, D. E., “Letter to editor”, J Vet Intern Med, 2015.

J. A. Hall, Yerramilli, M., Obare, E., Yerramilli, M., Melendez, L. D., and Jewell, D. E., “Letter to the Editor.”, J Vet Intern Med, vol. 30, no. 1, pp. 12-4, 2016.

J. A. Hall, Yerramilli, M., Obare, E., Yerramilli, M., Melendez, L. D., and Jewell, D. E., “Letter to the Editor.”, J Vet Intern Med, vol. 30, no. 1, pp. 12-4, 2016.

J. A. Hall, Fritsch, D. A., Yerramilli, M., Obare, E., Yerramilli, M., and Jewell, D. E., “A longitudinal study on the acceptance and effects of a therapeutic renal food in pet dogs with IRIS-Stage 1 chronic kidney disease.”, J Anim Physiol Anim Nutr (Berl), vol. 102, no. 1, pp. 297-307, 2018.

J. A. Hall, Fritsch, D. A., Yerramilli, M., Obare, E., Yerramilli, M., and Jewell, D. E., “A longitudinal study on the acceptance and effects of a therapeutic renal food in pet dogs with IRIS-Stage 1 chronic kidney disease.”, J Anim Physiol Anim Nutr (Berl), vol. 102, no. 1, pp. 297-307, 2018.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

S. Tripathi, Pohl, M. O., Zhou, Y., Rodriguez-Frandsen, A., Wang, G., Stein, D. A., Moulton, H. M., DeJesus, P., Che, J., Mulder, L. C. F., Yángüez, E., Andenmatten, D., Pache, L., Manicassamy, B., Albrecht, R. A., Gonzalez, M. G., Nguyen, Q., Brass, A., Elledge, S., White, M., Shapira, S., Hacohen, N., Karlas, A., Meyer, T. F., Shales, M., Gatorano, A., Johnson, J. R., Jang, G., Johnson, T., Verschueren, E., Sanders, D., Krogan, N., Shaw, M., König, R., Stertz, S., García-Sastre, A., and Chanda, S. K., “Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.”, Cell Host Microbe, vol. 18, no. 6, pp. 723-35, 2015.

B. P. Dolan, Sharma, A. A., Gibbs, J. S., Cunningham, T. J., Bennink, J. R., and Yewdell, J. W., “MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.”, Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 18, pp. 7025-30, 2012.

E. Fu, Nelson, K. E., Ramsey, S. A., Foley, J. O., Helton, K., and Yager, P., “Modeling of a competitive microfluidic heterogeneous immunoassay: sensitivity of the assay response to varying system parameters.”, Anal Chem, vol. 81, no. 9, pp. 3407-13, 2009.

Y. Yuan, Lyng, K., Zhang, Y. X., Rockey, D. D., and Morrison, R. P., “Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60.”, Infect Immun, vol. 60, no. 6, pp. 2288-96, 1992.

Y. Yuan, Lyng, K., Zhang, Y. X., Rockey, D. D., and Morrison, R. P., “Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60.”, Infection and immunity, vol. 60, no. 6, pp. 2288-96, 1992.

L. S. Young, Gascon, R., Alam, S., and Bermudez, L. E., “Monoclonal antibodies for treatment of gram-negative infections.”, Reviews of infectious diseases, vol. 11 Suppl 7, pp. S1564-71, 1989.

N. Ran, Lin, C., Leng, L., Han, G., Geng, M., Wu, Y., Bittner, S., Moulton, H. M., and Yin, H., “MOTS-c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice.”, EMBO Mol Med, vol. 13, no. 2, p. e12993, 2021.

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Mycobacteria and AIDS: treatment, prevention and future prospects.”, Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.

L. E. Bermudez, Inderlied, C. B., and Young, L. S., “Mycobacterium avium complex in AIDS.”, Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.

Y. Yamazaki, Danelishvili, L., Wu, M., Macnab, M., and Bermudez, L. E., “Mycobacterium avium genes associated with the ability to form a biofilm.”, Appl Environ Microbiol, vol. 72, no. 1, pp. 819-25, 2006.

Y. Yamazaki, Danelishvili, L., Wu, M., Macnab, M., and Bermudez, L. E., “Mycobacterium avium genes associated with the ability to form a biofilm.”, Applied and environmental microbiology, vol. 72, no. 1, pp. 819-25, 2006.

N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E., “Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”, Immunology, vol. 91, no. 3, pp. 414-20, 1997.

N. Mohagheghpour, Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E., and Young, L. S., “Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes.”, Cellular immunology, vol. 176, no. 1, pp. 82-91, 1997.

M. McNabe, Tennant, R., Danelishvili, L., Young, L., and Bermudez, L. E., “Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials.”, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 17, no. 5, pp. 697-703, 2011.

M. McNabe, Tennant, R., Danelishvili, L., Young, L., and Bermudez, L. E., “Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials.”, Clin Microbiol Infect, vol. 17, no. 5, pp. 697-703, 2011.

L. E. Bermudez, Kolonoski, P., and Young, L. S., “Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model.”, Journal of leukocyte biology, vol. 47, no. 2, pp. 135-41, 1990.

L. E. Bermudez and Young, L. S., “Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages.”, Journal of immunology (Baltimore, Md. : 1950), vol. 146, no. 1, pp. 265-70, 1991.